Author: Site Editor Publish Time: 08-04-2026 Origin: Site
In aesthetic medicine, the periorbital area remains one of the most challenging treatment areas due to its thin skin, complex anatomy, and multiple factors contributing to aging. Many patients ask: “Can Polynucleotides (PN) improve eye bags and dark circles?” The answer depends on the underlying cause and treatment goals.
Unlike dermal fillers, which primarily restore lost volume, or energy-based devices that focus on tightening, polynucleotides for eye bags, dark circles and under eye hollows work through a regenerative approach to improve the overall condition of aging skin.
For aesthetic clinics, PN provides an additional option for patients seeking more advanced skin improvement beyond hydration but who are not ready for volume-based correction.
Before choosing a treatment approach, practitioners should identify the main cause behind each periorbital concern.
Eye Concern | Visual Reference | Main Causes |
Eye Bags |  | Usually caused by orbital fat protrusion combined with skin laxity and weakened lower eyelid support. |
Dark Circles |  | May result from pigmentation, visible blood vessels, skin thinning, or shadowing caused by tear trough depression. Many patients present with mixed-type dark circles. |
Tear Trough Concerns |  | Mainly related to volume loss, orbital structural changes, and facial aging. |
Polynucleotides (PN) are purified DNA fragments derived from salmon or trout sources. Their main mechanisms include:
Supporting fibroblast activity: PN activates pathways associated with collagen and elastin production, helping improve skin firmness and elasticity.
Improving the skin microenvironment: PN supports hydration, tissue repair, and balanced inflammatory responses.
By supporting the skin’s natural repair process, PN helps improve under-eye skin thickness, firmness, and elasticity, particularly for patients with fine lines, thin skin, and a crepey appearance.
Hyaluronic acid fillers remain an important option for correcting structural volume loss, especially in patients with significant tear trough hollows. PN works differently by supporting skin remodeling rather than adding volume.
PN offers advantages in improving fine lines, skin texture, elasticity, and hydration, providing a unique approach to under-eye rejuvenation for this delicate treatment area.
For example, PNPure™ NeoEye is specifically developed for the delicate periorbital area, containing 1% high molecular weight PN (1260–1570 kDa) combined with supportive ingredients for professional eye rejuvenation protocols.
Based on clinical observations and real-world applications, PN eye treatments show gradual and progressive improvement.
PN may help improve static fine lines, crepey skin texture, and vascular or mixed-type dark circles associated with skin thinning.
PN results develop gradually rather than immediately. Multiple sessions are commonly recommended, with treatment intervals adjusted according to skin condition and patient response. Improvement usually continues over 1–3 months after completing the recommended treatment course.
Results may last around 6 months or longer depending on individual factors. Maintenance treatments can be considered every 6–12 months based on clinical assessment.
Patients with thin under-eye skin and static fine lines showing early periorbital aging;
Patients with vascular or mixed-type dark circles related to skin thinning;
Patients with mild tear trough concerns who do not want or are not suitable for HA fillers;
Patients after eye bag surgery who still experience uneven texture or residual fine lines.
Protruding eye bags (fat herniation): PN cannot remove herniated fat, and surgical correction may be required.
Severe pigment-type dark circles: Additional treatments such as laser or brightening therapies may be needed.
Active infections, autoimmune diseases, pregnancy, and breastfeeding: These are generally considered contraindications.
Which is better, Polynucleotides or dermal fillers for under-eye treatment?
Neither treatment is universally better. Fillers are mainly used for volume correction, while PN focuses on improving skin quality, elasticity, and fine lines. The choice depends on the patient’s specific concerns.
Will PN injections cause significant swelling?
Mild redness, swelling, or small injection bumps may occur after treatment. These reactions are usually temporary and typically resolve within hours to a few days.
How many sessions are needed?
Treatment frequency depends on skin condition, aging severity, and individual response. Most protocols involve multiple sessions followed by maintenance treatments based on clinical evaluation.
By improving the condition of aging skin, PN helps clinics meet the needs of patients seeking natural-looking eye rejuvenation without significant changes in facial volume. It works alongside dermal fillers and energy-based treatments rather than replacing them.
For clinics interested in expanding their eye rejuvenation treatments, contact us to explore PNPure™ NeoEye clinical applications and partnership opportunities.
